Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulator
Financiación FP7 / Fp7 Funds
Resumen: Although the bovine tuberculosis (TB) agent, Mycobacterium bovis, may infect humans and cause disease, long-term epidemiological data indicate that humans represent a spill-over host in which infection with M. bovis is not self-maintaining. Indeed, human-to-human transmission of M. bovis strains and other members of the animal lineage of the tubercle bacilli is very rare. Here, we report on three mutations affecting the two-component virulence regulation system PhoP/PhoR (PhoPR) in M. bovis and in the closely linked Mycobacterium africanum lineage 6 (L6) that likely account for this discrepancy. Genetic transfer of these mutations into the human TB agent, Mycobacterium tuberculosis, resulted in down-regulation of the PhoP regulon, with loss of biologically active lipids, reduced secretion of the 6-kDa early antigenic target (ESAT-6), and lower virulence. Remarkably, the deleterious effects of the phoPR mutations were partly compensated by a deletion, specific to the animal-adapted and M. africanum L6 lineages, that restores ESAT-6 secretion by a PhoPR-independent mechanism. Similarly, we also observed that insertion of an IS6110 element upstream of the phoPR locus may completely revert the phoPR-bovis–associated fitness loss, which is the case for an exceptional M. bovis human outbreak strain from Spain. Our findings ultimately explain the long-term epidemiological data, suggesting that M. bovis and related phoPR-mutated strains pose a lower risk for progression to overt human TB, with major impact on the evolutionary history of TB.
Idioma: Inglés
DOI: 10.1073/pnas.1406693111
Año: 2014
Publicado en: Proceedings of the National Academy of Sciences 111, 31 (2014), 11491-11496
ISSN: 0027-8424

Factor impacto JCR: 9.674 (2014)
Categ. JCR: MULTIDISCIPLINARY SCIENCES rank: 4 / 57 = 0.07 (2014) - Q1 - T1
Financiación: info:eu-repo/grantAgreement/ES/FEDER/POCTEFA-REFBIO-EFA237-11
Financiación: info:eu-repo/grantAgreement/ES/FIS/FIS12/1970
Financiación: info:eu-repo/grantAgreement/EC/FP7/241745/EU/Discovery and preclinical development of new generation tuberculosis vaccines/NEWTBVAC
Financiación: info:eu-repo/grantAgreement/EC/FP7/260872/EU/More Medicines for Tuberculosis/MM4TB
Financiación: info:eu-repo/grantAgreement/ES/MICINN/Juan de la Cierva Program-JCI-2009-03799
Financiación: info:eu-repo/grantAgreement/ES/MINECO/BIO2011-23555
Tipo y forma: Article (Published version)
Área (Departamento): Área Microbiología (Dpto. Microb.Med.Pr.,Sal.Públ.)

Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.


Exportado de SIDERAL (2019-05-29-11:41:45)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Articles



 Record created 2017-03-29, last modified 2019-05-29


Versión publicada:
 PDF
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)